{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["8(3)"],"submitter":["Martinez C"],"funding":["Bayer AG","Bayer"],"pubmed_abstract":["Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-based cohort study of patients with first VTE and no active cancer in England between 2001 and 2012. CTEPH was assessed using a rigorous case-ascertainment algorithm. Risk factors for CTEPH were studied using a nested case-control approach by matching CTEPH cases to VTE patients without CTEPH. Adjusted odds ratios (OR) of comorbidities were estimated from conditional logistic regression. During 81,413 person-years of follow-up among 23,329 patients with first VTE (mean follow-up "],"journal":["Pulmonary circulation"],"pagination":["2045894018791358"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6066824"],"repository":["biostudies-literature"],"pubmed_title":["Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England."],"pmcid":["PMC6066824"],"pubmed_authors":["Wallenhorst C","Cohen AT","Peacock AJ","Martinez C","Teal S"],"additional_accession":[]},"is_claimable":false,"name":"Incidence and risk factors of chronic thromboembolic pulmonary hypertension following venous thromboembolism, a population-based cohort study in England.","description":"Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-based cohort study of patients with first VTE and no active cancer in England between 2001 and 2012. CTEPH was assessed using a rigorous case-ascertainment algorithm. Risk factors for CTEPH were studied using a nested case-control approach by matching CTEPH cases to VTE patients without CTEPH. Adjusted odds ratios (OR) of comorbidities were estimated from conditional logistic regression. During 81,413 person-years of follow-up among 23,329 patients with first VTE (mean follow-up ","dates":{"release":"2018-01-01T00:00:00Z","publication":"2018 Jul-Sep","modification":"2025-04-04T20:29:43.258Z","creation":"2019-03-26T23:49:55Z"},"accession":"S-EPMC6066824","cross_references":{"pubmed":["29985100"],"doi":["10.1177/2045894018791358"]}}